Thomas Bachelot, MD, PhD, discusses therapies available for patients with HER2-positive breast cancer and brain metastases.
Thomas Bachelot, MD, PhD
Advertisement
Thomas Bachelot MD, PhD, is a medical oncologist and head of the clinical research unit at the Centre Leon Berard in Lyon, France.
Articles by Thomas Bachelot, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
2
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
3
Beyond SC Daratumumab: Emerging Therapeutic Approaches for Smoldering Myeloma
4
FDA Approves Liso-Cel as First CAR T for Marginal Zone Lymphoma
5
